This issue of Horizon looks at EU research which is holding out the promise of radical new treatments for cancer.
Around 1.8 million Europeans died of cancer last year, making it the second-biggest killer after cardiovascular disease. In November, Horizon looks at powerful new techniques that could improve cancer survival rates.
We look at technology that allows doctors to stay ahead of mutations in tumour cells by adapting treatments in real time, and we examine techniques that can turn a patient’s immune system against cancer.
For our Views section, Professor Martine Piccart, a former president of the European Organisation for Research and Treatment of Cancer, explains what is required to individualise cancer therapy, so that it matches the specific needs of each patient.
Professor Martine Piccart is a past president of the European Organisation for Research and Treatment of Cancer, Chair of the Breast International Group (BIG) and head of medicine at the Jules Bordet cancer hospital in Brussels. She explains that cancer research needs to change so that cancer treatment can become truly personalised.
As world leaders prepare to meet in Paris to try to agree ambitious emissions reduction goals, Horizon looks at EU research that is helping us understand how climate change will affect our lives, and how individuals and industries will have to adapt.
Yeast that tracks the stock market index, a woman who simulates giving birth to a dolphin baby and homemade human cheese are just a few projects that have emerged from collaborations between scientists and artists – and the result is to produce better science and innovation, say researchers.
Yeast tracks the stock market.
They’ve already worked in mice.
Leading a green lifestyle could help us be more satisfied, as well as having climate benefits, says Prof. García Mira.